Hai Liu

Dr. Hai Liu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2023 in Japanese Journal of Radiology
Verified
Journal Article
Closed access
PDF file
JSJingjing Shan
Jingjing Shan
XXXuyun Xie
Xuyun Xie
BGBenxing Gu
Benxing Gu
XSXiaonan Sun
Xiaonan Sun
HLHai Liu
Hai Liu

18 January 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
HLHai Liu
Hai Liu
RHRunying Huang
Runying Huang
JSJingjing Shan
Jingjing Shan
XXXuyun Xie
Xuyun Xie
WCWANG CHONGWEI
WANG CHONGWEI
XSXiaonan Sun
Xiaonan Sun
The aim of this study was to identify Artemis as a predictive biomarker for guiding preoperative chemoradiotherapy in locally advanced rectal cancer. The resection specimens were collected from 50 patients with rectal cancer who underwent preoperative chemoradiotherapy. Artemis expression in biopsy tissues was evaluated using immunohistochemical staining according to the percentage of positively stained cells combined with staining intensity. Among the 50 patients, 36 (72%) had a weakly positive Artemis protein expression, 10 (20%) had a moderately positive expression, and 4 (8%) showed a strongly positive expression. The criteria of magnetic resonance imaging tumor regression grade (mrTRG) and pathological rectal cancer regression grade (RCRG) were used to assess the tumor response to chemoradiotherapy. Correlation analysis shows that there is a significant negative correlation between high Artemis immunoscore and treatment response (r = −0.532, p < 0.001). The results imply that high Artemis expression was associated with poor treatment response. Our study suggested a potential role of Artemis as a predictive biomarker of the tumor response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.

11 October 2024 in Medicine
Verified
Journal Article
Open access
CSChong Shen
Chong Shen
HLHailong Liao
Hailong Liao
QWQi Wang
Qi Wang
HLHai Liu
Hai Liu
XSXiaonan Sun
Xiaonan Sun
This study aimed to investigate the influence of gantry angle increment (Inc) parameters on the Monaco treatment planning system for volumetric modulated arc therapy (VMAT) in right breast cancer, and to determine the optimal Inc parameters. Twenty-three patients with right breast cancer at the Sir Run Run Shaw Hospital from August 2022 to August 2023 were retrospectively selected. Four VMAT plans were generated for each patient incorporating Inc of 10°, 20° (control group), 30°, and 40°, while the other optimization parameters and constraint functions remained constant. The D98 and conformity index were lower in the Inc30 and Inc40 groups than in the Inc20 group. As Inc increased from 10° to 30°, the irradiated dose to the ipsilateral lung, including the V20, V5, and Dmax, mean dose, gradually increased. There were no statistically significant differences in the irradiated dose to the contralateral breast, contralateral lung, heart, esophagus, and brachial plexus. The number of monitor units and control points decreased with increasing Inc. Smaller Inc values can achieve higher target coverage and lower irradiated dose to the ipsilateral lung, but will reduce delivery efficiency. Considering the plan quality and delivery efficiency, an Inc of 10° or 20° is recommended for right breast cancer VMAT plans.

15 February 2026 in International Immunopharmacology
Verified
Journal Article
Open access
YZYunjie Zhang
Yunjie Zhang
JSJingjing Shan
Jingjing Shan
RHRunyin Huang
Runyin Huang
WWWei Wei
Wei Wei
HLHai Liu
Hai Liu
This study compares stereotactic body radiotherapy (SBRT) alone versus SBRT combined with immunotherapy (SBRT+IT) for pulmonary metastases. In a retrospective analysis of patients from Sir Run Run Shaw Hospital, cohorts were balanced using propensity score matching. While local control was similar between groups, the SBRT+IT group demonstrated a significantly superior median overall survival (51.3 vs. 35.5 months, P < 0.05), indicating a systemic benefit from immunotherapy. Multivariable analysis identified C-reactive protein (CRP), the CRP-to-albumin ratio (CAR), and the CRP-to-lymphocyte ratio (CLR) as independent prognostic factors for SBRT+IT outcomes, with low baseline levels predicting longer survival. The receiver operating characteristic analysis demonstrated three markers possessed good to excellent predictive ability for short-term survival. We conclude that combining SBRT with immunotherapy significantly improves survival compared to SBRT alone, primarily through systemic immune activation rather than enhanced local tumor control. Furthermore, CRP, CAR, and CLR serve as robust prognostic biomarkers for this combination strategy, highlighting the clinical value of this synergistic approach for improving the prognosis of patients with lung metastases.

28 May 2026 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YZYunjie Zhang
Yunjie Zhang
JSJingjing Shan
Jingjing Shan
BGBenxing Gu
Benxing Gu
RHRunying Huang
Runying Huang
HLHai Liu
Hai Liu
Objective: Malnutrition is a significant and modifiable prognostic factor in patients with pulmonary metastases undergoing stereotactic body radiotherapy (SBRT). This study evaluated and compared the prognostic utility of four nutritional assessment tools—Nutritional Risk Index (NRI), Controlling Nutritional Status (CONUT), Nutritional Risk Screening 2002 (NRS), and Prognostic Nutritional Index (PNI)—to identify malnutrition patients and inform potential interventions for improving survival. Methods: In this retrospective cohort study of 185 patients with pulmonary metastases treated with SBRT, nutritional status was assessed using the NRI, CONUT, NRS, and PNI. The primary endpoint was overall survival (OS). Statistical analyses encompassed survival analysis, subgroup exploration, correlation assessment, and development of an integrated prognostic model. Results: Malnutrition prevalence varied: 65.95% (NRI), 63.78% (CONUT), 77.84% (NRS), and 79.46% (PNI) of patients had some nutritional impairment. Multivariable analysis identified CONUT (HR = 1.09) and NRI (HR = 3.99) as independent prognostic factors for OS. An integrated model combining nutritional (CONUT, NRI) and clinical variables showed superior predictive performance (C-index: 0.681) compared to any single tool. Conclusion: Malnutrition is highly prevalent and prognostic in SBRT-treated lung metastasis patients. CONUT and NRI are effective for risk stratification. The integrated model offers a superior prognostic tool, supporting the routine integration of these nutritional assessments into clinical practice to identify high-risk patients for timely intervention.